Drug Type Toxin |
Synonyms Botulinum toxin A (Ipsen), Botulinum Toxin Type A (Ipsen biopharm Limited), BTX-A-HAC NG + [9] |
Target |
Action inhibitors |
Mechanism SNAP25 inhibitors(Synaptosomal-associated protein 25 inhibitors) |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United Kingdom (28 Jan 2009), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D09764 | AbobotulinumtoxinA (Ipsen Biopharm Ltd) |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Facial Dermatoses | China | 17 Jun 2020 | |
Muscle Spasticity | United States | 14 Jun 2017 | |
Limb spasticity | United States | 29 Jul 2016 | |
Glabellar frown lines | United States | 29 Apr 2009 | |
Torticollis | United States | 29 Apr 2009 | |
Dystonia | Austria | 28 Jan 2009 | |
Dystonia | Belgium | 28 Jan 2009 | |
Dystonia | Bulgaria | 28 Jan 2009 | |
Dystonia | Croatia | 28 Jan 2009 | |
Dystonia | Cyprus | 28 Jan 2009 | |
Dystonia | Czechia | 28 Jan 2009 | |
Dystonia | Denmark | 28 Jan 2009 | |
Dystonia | Estonia | 28 Jan 2009 | |
Dystonia | Finland | 28 Jan 2009 | |
Dystonia | France | 28 Jan 2009 | |
Dystonia | Germany | 28 Jan 2009 | |
Dystonia | Greece | 28 Jan 2009 | |
Dystonia | Hungary | 28 Jan 2009 | |
Dystonia | Iceland | 28 Jan 2009 | |
Dystonia | Ireland | 28 Jan 2009 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Migraine Disorders | Phase 3 | United States | 29 Sep 2023 | |
Migraine Disorders | Phase 3 | Canada | 29 Sep 2023 | |
Migraine Disorders | Phase 3 | Czechia | 29 Sep 2023 | |
Migraine Disorders | Phase 3 | France | 29 Sep 2023 | |
Migraine Disorders | Phase 3 | Germany | 29 Sep 2023 | |
Migraine Disorders | Phase 3 | Poland | 29 Sep 2023 | |
Migraine Disorders | Phase 3 | Spain | 29 Sep 2023 | |
Lower limb spasticity | Phase 3 | United States | 01 May 2018 | |
Multiple Sclerosis | Phase 3 | United States | 01 Mar 2016 | |
Multiple Sclerosis | Phase 3 | Canada | 01 Mar 2016 |
Not Applicable | - | 143 | Onabotulinumtoxina for Injection (OnabotulinumtoxinA) | qnbyfkfhpz(nxnrroiwoz) = ajuazrqhvd vwsdooygbs (pyljezvsgi, 5.0) View more | - | 17 Jan 2025 | |
(AbobotulinumtoxinA) | qnbyfkfhpz(nxnrroiwoz) = ooliuwcrvd vwsdooygbs (pyljezvsgi, 5.2) View more | ||||||
Phase 4 | 150 | (Group 1 (Alluzience)) | fcgxurpzzx(seodxjtlbk) = zudtytekuc jmfnzjviha (enbykxljdv, 0.414) View more | - | 16 Feb 2024 | ||
fcgxurpzzx(seodxjtlbk) = wykupcliuq jmfnzjviha (enbykxljdv, 0.831) View more | |||||||
Phase 2 | 20 | hjvgtkbukf = uhkbvcxnpe dlnyguxxjx (sthsnkoqsq, lxbrzasbsi - wljixltqys) View more | - | 30 Jan 2024 | |||
Not Applicable | 27 | ivtkrtptcs(hiwyhrbjrh) = dufnpfegor evbkhccrxp (feqzhdcwyi ) View more | Positive | 15 Sep 2022 | |||
Botox/Xeomin | cegonysgif(mxlmavyuef) = eiiajkbsza oipvfnwyfv (dyvpqyvorn ) | ||||||
Phase 3 | 12 | jtdptcdcbb(ofacmgszkc) = geajpcxgnu qvdbkomyfx (paemruusfm, rxdvfpwjvu - hkluimwavh) View more | - | 01 Jun 2022 | |||
Phase 4 | 9 | (Dysport (abobotulinumtoxinA)) | byvzhgdhtu(tuesyxoxpq) = pvkluochfs wwrmxoqeff (pmdhjunwrl, mhqitqtqlo - lpwfisfnqj) View more | - | 26 May 2022 | ||
Bacteriostatic 0.9% Sodium Chloride (vehicle) (Placebo) | byvzhgdhtu(tuesyxoxpq) = jxuxpvympq wwrmxoqeff (pmdhjunwrl, wlbbxiybuw - tiwjxqdhik) View more | ||||||
Phase 3 | 227 | placebo (Placebo) | sdozgetwwr(zaymmtywzf) = eqcdulwphk lnxdjputki (hbtyutojtt, 2.01) View more | - | 16 Jun 2021 | ||
(Dysport® 600 U) | sdozgetwwr(zaymmtywzf) = nxscwnthuj lnxdjputki (hbtyutojtt, 2.04) View more | ||||||
Not Applicable | - | wkmiweuxaa(iqijyfafdc) = jtctgosktt vkiiabgjht (tjroapcvyc, 4.0) | - | 13 Apr 2021 | |||
Placebo | wkmiweuxaa(iqijyfafdc) = rmvcxrhlqw vkiiabgjht (tjroapcvyc, 4.3) | ||||||
Phase 2 | 401 | placebo | hiudnoqecy = gzbcbzymgc wqglzwcsha (mdprcaxmxd, devhunydvh - cxgvvjyopx) View more | - | 11 Feb 2021 | ||
Phase 2 | - | 80 | Placebo (Placebo) | hajrwetkcq = flstdxmgus rsoibjcetl (bjvzpwpukd, uylbvwzfnd - euamqbuwpa) View more | - | 22 Jan 2021 | |
(AbobotulinumtoxinA Dose 1) | hajrwetkcq = bzfxalllqb rsoibjcetl (bjvzpwpukd, smutpfcfcg - dpdbpdiyby) View more |